|Articles|January 18, 2021
Supplements and Featured Publications
- COPD Stakeholder Summit: Utilizing Peak Inspiratory Flow Rates to Individualize Treatment and Improve Outcomes
Chronic Obstructive Pulmonary Disease Stakeholder Summit: Utilizing Peak Inspiratory Flow Rates to Individualize Treatment and Improve Outcomes
Advertisement
This activity is supported by an educational grant from Boehringer Ingelheim.
This AJMC® Stakeholder Summit provides a multistakeholder perspective on current treatment options, recent guideline recommendations, and approaches for health care decision makers and clinicians for the individualized management of chronic obstructive pulmonary disease (COPD).
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
5 Things to Know About the Oral GLP-1 Era
5
